Atlas Trials

Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder

Clinical trial NCT06633315 · COMPLETED

Trial details

NCT number
NCT06633315
Sponsor
Maternal and Child Health Hospital of Hubei Province
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum DisorderDexmedetomidineEsketamineSedation
Start date
2022-12-01
Primary completion
2024-09-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.